• Home
  • Search Results

Search Results

Older Adult (65+)
2054 studies match your search
Open

Registry of patients with EoE treated with Dupixent

This study is researching the treatment outcomes and long-term effects of a drug called Dupixent in treatment of patients with Eosinophilic Esophagitis (EoE).

Age & Gender
  • 12 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Stomach, Digestion and Gut Health
  • Ear, Nose, and Throat
Visit Location
100% Remote (online, phone, text)
Coming Soon

Leukemia Treatment Study

In this study, we want to see how well a new drug called Quizartinib works for people with Leukemia who do not have a specific mutation called FLT3-ITD. We want to see if this new drug helps improve the condition.

Age & Gender
  • 18 years ~ 70 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

MB-105 in Patients with CD5 Positive Relapsed/Refractory T-Cell Lymphoma

Do you have T-cell Lymphoma? Is your disease relapsed or refractory and CD5 positive? If so, you may be able to participate in this gene therapy research study to learn more about using your own modified immune cells as possible treatment.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Not currently enrolling

Sexual Violence Survivor Study

In this study, we are trying to understand how students feel when they look for help after going through sexual misconduct or violence. We also want to find ways to support those who have been affected.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
  • UNC Students (undergrad, grad, professional)
Visit Location
100% Remote (online, phone, text)
Open

C-section Infection Prevention Study

Are you pregnant? Are you planning a scheduled cesarean delivery? If so, you may be able to take part in a study to see if using two antibiotics before a C-section instead of just one can lower the risk of infections. The infections we want to prevent are womb infection, wound infection, or a serious blood infection. Compensation provided.

Age & Gender
  • 14 years ~ 99 years
  • Female
Study Interest
  • Pregnancy
Visit Location
100% Remote (online, phone, text)
Open

Petosemtamab Drug Study

Do you have incurable, metastatic/recurrent head and neck squamous cell carcinoma? If so, you may be able to take part in a study to see if a new drug called petosemtamab is effective. We want to see if petosemtamab works better than the treatments doctors usually use for head and neck squamous cell carcinoma. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck)
Open

Study of RP1 in Organ and Cell Transplant Patients With Skin Cancer

Have you had an organ transplant or hematopoietic cell transplant and have advanced cutaneous squamous cell carcinoma? If so, you might be eligible to take part in a study to see if an investigation drug, RP1, can help treat your skin cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Other Cancers)
Not currently enrolling

University Financial Aid Website Study

Participants will meet with me on a recorded Zoom session for about 1 hour in exchange for a $20 Starbucks gift card. During this call, I'll have them complete a few tasks on the cost and financial aid pages of a few different university websites. They will not be asked to provide any personal information to these sites. The purpose of my study is to understand the challenges first-generation students and their families run into when trying to understand the cost of attending college on university websites.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Language and Speech
  • UNC Students (undergrad, grad, professional)
Visit Location
100% Remote (online, phone, text)
Not currently enrolling

Radiation-Induced Xerostomia Long-Term Follow-Up Study

In this study, we want to asses the long-term safety of using a virus to deliver a gene, AAV2-hAQP1, and how effective this gene is at treating dry mouth in people who have received radiation therapy for head and neck cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck)

Dara-RVd Induction for newly diagnosed multiple myeloma with autologous stem cell transplantation

In this study, we want to see what happens when one of the drugs in a 4-drug combination called Dara-RVd is given once a week instead of twice a week. We will look at how this timing change affects the outcome of multiple myeloma with autologous stem cell transplantation. This is a hybrid decentralized study where some if not all assessments may be performed close to your home.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Multiple Myeloma)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research